Herrero-Vanrell R - Search Results

1

Trojan Microparticles Potential for Ophthalmic Drug Delivery.

Esteban-Pérez S, Bravo-Osuna I, Andrés-Guerrero V, Molina-Martínez IT, Herrero-Vanrell R. Esteban-Pérez S, et al. Curr Med Chem. 2020;27(4):570-582. doi: 10.2174/0929867326666190905150331. Curr Med Chem. 2020. PMID: 31486746 Review.

2

Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.

Fernández-Carballido A, Herrero-Vanrell R, Molina-Martínez IT, Pastoriza P. Fernández-Carballido A, et al. Int J Pharm. 2004 Jul 26;279(1-2):33-41. doi: 10.1016/j.ijpharm.2004.04.003. Int J Pharm. 2004. PMID: 15234792

3

Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release.

Herrero-Vanrell R, Rincón AC, Alonso M, Reboto V, Molina-Martinez IT, Rodríguez-Cabello JC. Herrero-Vanrell R, et al. J Control Release. 2005 Jan 20;102(1):113-22. doi: 10.1016/j.jconrel.2004.10.001. J Control Release. 2005. PMID: 15653138

4

Sterilized ibuprofen-loaded poly(D,L-lactide-co-glycolide) microspheres for intra-articular administration: effect of gamma-irradiation and storage.

Fernández-Carballido A, Herrero-Vanrell R, Molina-Martínez IT, Pastoriza P. Fernández-Carballido A, et al. J Microencapsul. 2004 Sep;21(6):653-65. doi: 10.1080/09687860400008437. J Microencapsul. 2004. PMID: 15762322

5

Biocompatibility of elastin-like polymer poly(VPAVG) microparticles: in vitro and in vivo studies.

Rincón AC, Molina-Martinez IT, de Las Heras B, Alonso M, Baílez C, Rodríguez-Cabello JC, Herrero-Vanrell R. Rincón AC, et al. J Biomed Mater Res A. 2006 Aug;78(2):343-51. doi: 10.1002/jbm.a.30702. J Biomed Mater Res A. 2006. PMID: 16646066

6

[Potential of dendrimers as drug carriers in Ophthalmology].

Bravo-Osuna I, Herrero-Vanrell R. Bravo-Osuna I, et al. Arch Soc Esp Oftalmol. 2007 Feb;82(2):69-70. doi: 10.4321/s0365-66912007000200002. Arch Soc Esp Oftalmol. 2007. PMID: 17323244 Spanish. No abstract available.

7

[New formulations for dry eye treatment].

Vicario-de-la-Torre M, Herrero-Vanrell R, Benítez-del-Castillo JM, Molina-Martínez IT. Vicario-de-la-Torre M, et al. Arch Soc Esp Oftalmol. 2007 Jul;82(7):395-6. doi: 10.4321/s0365-66912007000700002. Arch Soc Esp Oftalmol. 2007. PMID: 17647113 Spanish. No abstract available.

8

[Autologous serum in the treatment of dry eye syndrome. Technological aspects].

Herrero-Vanrell R, Molina-Martínez I. Herrero-Vanrell R, et al. Arch Soc Esp Oftalmol. 2008 Sep;83(9):521-3. doi: 10.4321/s0365-66912008000900002. Arch Soc Esp Oftalmol. 2008. PMID: 18803122 Spanish. No abstract available.

9

Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.

Andrés-Guerrero V, Alarma-Estrany P, Molina-Martínez IT, Peral A, Herrero-Vanrell R, Pintor J. Andrés-Guerrero V, et al. Exp Eye Res. 2009 Mar;88(3):504-11. doi: 10.1016/j.exer.2008.11.004. Epub 2008 Nov 14. Exp Eye Res. 2009. PMID: 19056382

10

[Ocular drug absorption by topical route. Role of conjunctiva].

Andrés-Guerrero V, Herrero-Vanrell R. Andrés-Guerrero V, et al. Arch Soc Esp Oftalmol. 2008 Dec;83(12):683-5. doi: 10.4321/s0365-66912008001200001. Arch Soc Esp Oftalmol. 2008. PMID: 19085638 Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page